Showing 461-470 of 856 results for "".
- New Soft Tissue Substitute Shows Promise for Correcting Defectshttps://modernaesthetics.com/news/new-soft-tissue-substitute-may-help-patients-avoid-certain-surgeries/2471918/A newly invented synthetic soft tissue substitute may hold advantages over currently available fillers, fat and implants when treating defects. The new composite is well tolerated and encourages the growth of soft tissue and blood vessels. It also retains its shape without being too dense
- Soliton, Inc.'s New Rapid Acoustic Pulse Device May Speed Laser Tattoo Removalhttps://modernaesthetics.com/news/soliton-incs-new-rapid-acoustic-pulse-device-may-speed-laser-tattoo-removal/2471982/Soliton, Inc. is introducing new acoustic shockwave technology for quicker laser tattoo removal. What’s more, the new device also shows potential in aesthetics market for cellulite and fat removal. The pate
- Sex and the City's Kristin Davis Partners with Coolsculpting for Denim Denial Programhttps://modernaesthetics.com/news/sex-and-the-citys-kirstin-davis-partners-with-coolsculpting-for-denim-denial-program/2472005/"Sex and the City” star Kristin Davis, is partnering with CoolSculpting for the new "Denim Denial" consumer program.Denim Denial recognizes that every woman has a pair of jeans on the top shelf of her closet or tucked away in a bottom drawer but is holding on to them with the
- NuEra Tight Radio Frequency Device Now Available from Lumenishttps://modernaesthetics.com/news/nuera-tight-radio-frequency-device-now-available-from-lumenis/2472008/Lumenis has launched NuEra tight, a non-invasive, intelligent temperature-controlled technology for both superficial and deep heating that treats a variety of conditions, such as skin
- Introducing Juvéderm It, Allergan's Newest Ad Campaignhttps://modernaesthetics.com/news/introducing-juvderm-it-allergans-newest-ad-campaign/2472020/Allergan plc is rolling out a new Juvéderm advertising campaign that aims to make this family of fillers a household name. Comprising a modernized logo, a bright, poppy color scheme, an edgy soundtrack and robust social media component, Juvéderm It is the first new adv
- Cynosure's TempSure™ Envi Set to Debut at 2018 AAD Meetinghttps://modernaesthetics.com/news/cynosures-tempsure-envi-set-to-debut-at-2018-aad-meeting/2472144/Hologic's Cynosure division is launching TempSure™ Envi – an FDA-cleared advanced radiofrequency device. TempSure™ Envi heats the deep layers of skin to regenerate collagen and
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- NFL Analyst Deion Sanders Named New Brand Ambassador for Botox Cosmetichttps://modernaesthetics.com/news/nfl-analyst-deion-sanders-named-new-brand-ambassador-for-botox-cosmetic/2472201/NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan also released two vide
- Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studieshttps://modernaesthetics.com/news/restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit-in-phase-4-studies/2472251/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na